Remdesivir modifies interferon response in hospitalized COVID-19 patients

Detalles Bibliográficos
Autores principales: Murphy, Sarah L., Halvorsen, Bente, Barratt-Due, Andreas, Dyrhol-Riise, Anne Ma, Aukrust, Pål, Trøseid, Marius, Dahl, Tuva B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338165/
https://www.ncbi.nlm.nih.gov/pubmed/35914611
http://dx.doi.org/10.1016/j.jinf.2022.07.021
_version_ 1784759909611470848
author Murphy, Sarah L.
Halvorsen, Bente
Barratt-Due, Andreas
Dyrhol-Riise, Anne Ma
Aukrust, Pål
Trøseid, Marius
Dahl, Tuva B.
author_facet Murphy, Sarah L.
Halvorsen, Bente
Barratt-Due, Andreas
Dyrhol-Riise, Anne Ma
Aukrust, Pål
Trøseid, Marius
Dahl, Tuva B.
author_sort Murphy, Sarah L.
collection PubMed
description
format Online
Article
Text
id pubmed-9338165
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-93381652022-08-01 Remdesivir modifies interferon response in hospitalized COVID-19 patients Murphy, Sarah L. Halvorsen, Bente Barratt-Due, Andreas Dyrhol-Riise, Anne Ma Aukrust, Pål Trøseid, Marius Dahl, Tuva B. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-11 2022-07-30 /pmc/articles/PMC9338165/ /pubmed/35914611 http://dx.doi.org/10.1016/j.jinf.2022.07.021 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Murphy, Sarah L.
Halvorsen, Bente
Barratt-Due, Andreas
Dyrhol-Riise, Anne Ma
Aukrust, Pål
Trøseid, Marius
Dahl, Tuva B.
Remdesivir modifies interferon response in hospitalized COVID-19 patients
title Remdesivir modifies interferon response in hospitalized COVID-19 patients
title_full Remdesivir modifies interferon response in hospitalized COVID-19 patients
title_fullStr Remdesivir modifies interferon response in hospitalized COVID-19 patients
title_full_unstemmed Remdesivir modifies interferon response in hospitalized COVID-19 patients
title_short Remdesivir modifies interferon response in hospitalized COVID-19 patients
title_sort remdesivir modifies interferon response in hospitalized covid-19 patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338165/
https://www.ncbi.nlm.nih.gov/pubmed/35914611
http://dx.doi.org/10.1016/j.jinf.2022.07.021
work_keys_str_mv AT murphysarahl remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT halvorsenbente remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT barrattdueandreas remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT dyrholriiseannema remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT aukrustpal remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT trøseidmarius remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients
AT dahltuvab remdesivirmodifiesinterferonresponseinhospitalizedcovid19patients

Ejemplares similares